Alnylam Pharmaceuticals (ALNY) P/E (2010 - 2026)
Alnylam Pharmaceuticals (ALNY) P/E from Mar 31, 2010 to Jul 21, 2026. The TTM Alnylam Pharmaceuticals (ALNY) P/E is 114.68. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Alnylam Pharmaceuticals (ALNY)
| Year | P/E | Change |
|---|---|---|
| 2026 | 114.68 | -31.76% |
| 2025 | 168.05 | -254.76% |
| 2024 | -108.59 | +133.03% |
| 2023 | -46.60 | +90.87% |
| 2022 | -24.41 | +3.19% |
| 2021 | -23.66 | +35.30% |
| 2020 | -17.49 | +21.77% |
| 2019 | -14.36 | +48.73% |
| 2018 | -9.66 | -60.61% |
| 2017 | -24.51 | +197.09% |
| 2016 | -8.25 | -69.98% |
| 2015 | -27.49 | +34.68% |
| 2014 | -20.41 | -55.14% |
| 2013 | -45.50 | +405.00% |
| 2012 | -9.01 | +30.70% |
| 2011 | -6.89 | -27.70% |
| 2010 | -9.54 | N/A |
Comparison Alnylam Pharmaceuticals (ALNY) P/E with competitors
Alnylam Pharmaceuticals (ALNY) P/E is 114.68.